Advances in Differentiated Service Delivery (DSD) and antiretroviral drug optimization in Zimbabwe have made HIV care and treatment more acceptable and effective, leading to greater coverage and better health outcomes—especially for patients with advanced or unstable HIV.
With an in-depth understanding of the status of the national HIV epidemic through the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) surveys conducted in 2016 and 2020, ICAP has continued working to improve service quality, strengthen human resources for health, and build capacity in epidemiology and strategic information (SI) for evidence-based HIV programs, policy and response.
Optimizing Differentiated Service Delivery for People Living with HIV (PLHIV) in Urban Zimbabwe: Assessing urban PLHIV preferences for treatment delivery models using a discrete choice experimentDistricts (or national):Harare
ICAP in Zimbabwe
Key Technical Areas
- Capacity Building of Health Workforce
- DREAMS (Women’s HIV Prevention)
- Health Information Systems
- Key / Priority Populations
- Implementation Science / Operations Research
- Laboratory Support
- Monitoring & Evaluation / SI
- Recency Testing
- Treatment Optimization
Bill & Melinda Gates Foundation
U.S. President’s Emergency Program for AIDS Relief (PEPFAR) / Centers for Disease Control and Prevention (CDC)
PEPFAR / Health Resources & Services Administration (HRSA)
Wits Reproductive Health Initiative
Tafadzwa Dzinamarira, MSc, MPH, PhD
Tafadzwa Dzinamarira, MSc, MPH, PhD, is ICAP’s interim country director in Zimbabwe. He is a public health expert with a strong background in clinical and epidemiological research, and more than seven years of experience providing technical support for public health systems and clinical laboratories strengthening the management of HIV/AIDS programs. Dr. Dzinamarira has expertise in providing technical leadership in the design, development, planning, and implementation, of national household-based biomarker surveys. Tafadzwa holds a Master of Science in HIV/AIDS Management, a Master of Public Health (Disease Prevention and Control), and a Doctor of Philosophy in Public Health Medicine. Prior to this role, Dr. Dzinamarira was the Regional Laboratory Technical Advisor for the PHIA project where he successfully supported the implementation of national HIV impact assessment surveys in Namibia, Rwanda, Haiti, Eswatini, Lesotho, Malawi, Mozambique, Uganda, Tanzania, and Zimbabwe. Prior to joining ICAP, Tafadzwa worked for the University of Zimbabwe Department of Medicine on a series of prospective operation research aimed at decreasing mortality associated with initiation of antiretroviral therapy in Sub-Saharan Africa through early detection and prevention of cryptococcal disease in Zimbabwe. Prior to joining the University of Zimbabwe, Tafadzwa worked for UCSF on a study that investigated HIV-target cell response in women initiating various contraceptive methods in high HIV-incidence areas.